Table 1.
Subjects | AD | Control |
---|---|---|
Sample number_n | 73 | 27 |
Gender-Female_n (%) | 41 (56.2) | 15 (55.6) |
APOE e4_n (%) | 55 (75.3) | 9 (33.3) |
Age at death_mean (SD) | 85.88 (7.3) | 88.44 (7.5) |
Age at onset_mean (SD) | 76.34 (9.6) | N/A |
Disease Duration_mean (SD) | 9.55 (4.8) | N/A |
Postmortem interval_mean hour (SD) | 5.06 (1.8) | 5.04 (2.4) |
CERAD Score | ||
Absent | 0 | 9 |
Sparse | 0 | 9 |
Moderate | 11 | 7 |
Frequent | 62 | 2 |
BRAAK Stage | ||
I | 0 | 5 |
II | 0 | 12 |
III | 0 | 10 |
IV | 0 | 0 |
V | 20 | 0 |
VI | 53 | 0 |